JNPMEDI Signs Strategic Business Agreement with SCL Healthcare for Maven-Central Lab Linked Services
JNPMEDI
JNPMEDI announced on the 25th that it had signed a strategic business agreement (MOU) with SCL Healthcare for a linked service between Maven and Central Lab (hereinafter referred to as C-LAB).
JNPMEDI x SCL Healthcare MOU
JNPMEDI announced on the 25th that it had signed a strategic business agreement with SCL Healthcare for a linked service between Maven and Central Lab (hereinafter referred to as C-LAB).
Through this agreement, we plan to cooperate with each other to establish C-LAB data standards for SCL Healthcare and establish automated linkage services based on JNPMEDI's clinical trial data management solution, CDMS (Clinical Data Management System).
SCL Healthcare C-LAB was established in 2006 as Korea's first clinical trial agency specializing in analysis and has various sample analysis and biomarker validation experiences, including new drug-licensed clinical trial tasks.
Under this agreement, the two companies are expected to significantly improve the efficiency of the staff's work by automatically linking C-LAB's analysis data with Maven CDMS's clinical trial data.
Starting with this service, the two companies will continue to discover areas for upgrading C-LAB operations through Maven CDMS and develop related solutions.